Palvella Therapeutics, Inc. (PVLA) vs Recursion Pharmaceuticals, Inc. (RXRX)
Palvella Therapeutics, Inc. and Recursion Pharmaceuticals, Inc. are both Biotechnology companies. Palvella Therapeutics, Inc. and Recursion Pharmaceuticals, Inc. are of similar size ($2.1B and $2.1B). Palvella Therapeutics, Inc. grew revenue faster over the last twelve months: 142.9% against −15.1%. Palvella Therapeutics, Inc. has the higher net margin (0.00% vs −945.9%) and the higher return on invested capital (0.00% vs −92.2%). Across the 18 metrics below, Palvella Therapeutics, Inc. leads on 13 and Recursion Pharmaceuticals, Inc. on 5.
Valuation
Profitability
| Metric | PVLA | RXRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 3.48% | 65.16% |
| Operating margin | 0.00% | (991.72%) | 0.00% |
| Net margin | 0.00% | (945.92%) | 0.00% |
| Free cash flow margin | 0.00% | (645.82%) | 0.00% |
| Return on equity | (46.63%) | (56.58%) | (57.72%) |
| Return on assets | (37.70%) | (41.26%) | (49.22%) |
| Return on invested capital | 0.00% | (92.22%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack